Nigeria and Bangladesh have embarked on new routine human papillomavirus (HPV) vaccine roll-out campaigns with the aim of reaching millions of girls and protecting them against the virus that causes nearly all cases of cervical cancer.
Nigeria and Bangladesh have embarked on new routine human papillomavirus (HPV) vaccine roll-out campaigns with the aim of reaching millions of girls and protecting them against the virus that causes nearly all cases of cervical cancer.
For Additional News from OncWeekly – Your Front Row Seat To The Future of Cancer Care –
Trusted insights straight to your inbox and get the latest updates from OncWeekly
Privacy Policy